SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-21-015167
Filing Date
2021-08-02
Accepted
2021-08-02 16:25:34
Documents
16
Period of Report
2021-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cerc-20210802.htm   iXBRL 8-K 35177
2 EX-99.1 ex-991earningsrelease2q2021.htm EX-99.1 133010
3 EX-99.2 ex-992horizon10mdrawdown.htm EX-99.2 20724
7 GRAPHIC cerecorlogoa71b.jpg GRAPHIC 16081
8 GRAPHIC cerecorlogoa71.jpg GRAPHIC 16081
  Complete submission text file 0001628280-21-015167.txt   384141

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cerc-20210802.xsd EX-101.SCH 1949
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cerc-20210802_lab.xml EX-101.LAB 23312
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cerc-20210802_pre.xml EX-101.PRE 12151
9 EXTRACTED XBRL INSTANCE DOCUMENT cerc-20210802_htm.xml XML 9975
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37590 | Film No.: 211136347
SIC: 2834 Pharmaceutical Preparations